Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson H Miller

Showing results (51-60 of 168) with videos related to

Pageof 17
Sort By:
Frontiers in Pharmacology|October 19, 2011
Resistance to cancer treatment: the role of somatic genetic events and the challenges for targeted therapiesGerald Batist, Jian Hui Wu, Alan Spatz, et al.
Plos One|December 20, 2016
Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast CancerCristiano Ferrario, Ivan Strepponi, Khashayar Esfahani, et al.
Virology Journal|November 15, 2013
In vitro inhibition of mumps virus by retinoidsKaitlin J Soye, Claire Trottier, Thomas Z Di Lenardo, et al.
Journal of Neuropathology and Experimental Neurology|May 8, 2007
Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairmentMichael I Assaraf, Zuanel Diaz, Adrienne Liberman, et al.
Cancer Research|January 2, 2009
Inhibition of DNA methyltransferase activates tumor necrosis factor alpha-induced monocytic differentiation in acute myeloid leukemia cellsAnna Laurenzana, Luca A Petruccelli, Filippa Pettersson, et al.
Cancer|June 16, 2010
Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer: impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitorsVictor Cohen, Jason S Agulnik, Celina Ang, et al.
Plos One|April 8, 2015
High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trialL John Hoffer, Line Robitaille, Robert Zakarian, et al.
Journal for Immunotherapy of Cancer|November 28, 2025
JAK inhibitors for the treatment of life-threatening and refractory immune-related adverse events secondary to immune checkpoint inhibitors: a prospective cohort studyRami Habib, Wilson H Miller, Theodore Papadopoulos, et al.
Blood|August 21, 2004
Expression of SMRTbeta promotes ligand-induced activation of mutated and wild-type retinoid receptorsSylvie Côté, Suzan McNamara, Daria Brambilla, et al.
Cancer|November 11, 2006
Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancerVictor Cohen, Jason S Agulnik, Jonathan Jarry, et al.
Pageof 17

Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
Frontiers in Pharmacology|October 19, 2011
Resistance to cancer treatment: the role of somatic genetic events and the challenges for targeted therapiesGerald Batist, Jian Hui Wu, Alan Spatz, et al.
Plos One|December 20, 2016
Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast CancerCristiano Ferrario, Ivan Strepponi, Khashayar Esfahani, et al.
Virology Journal|November 15, 2013
In vitro inhibition of mumps virus by retinoidsKaitlin J Soye, Claire Trottier, Thomas Z Di Lenardo, et al.
Journal of Neuropathology and Experimental Neurology|May 8, 2007
Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairmentMichael I Assaraf, Zuanel Diaz, Adrienne Liberman, et al.
Cancer Research|January 2, 2009
Inhibition of DNA methyltransferase activates tumor necrosis factor alpha-induced monocytic differentiation in acute myeloid leukemia cellsAnna Laurenzana, Luca A Petruccelli, Filippa Pettersson, et al.
Cancer|June 16, 2010
Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer: impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitorsVictor Cohen, Jason S Agulnik, Celina Ang, et al.
Plos One|April 8, 2015
High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trialL John Hoffer, Line Robitaille, Robert Zakarian, et al.
Journal for Immunotherapy of Cancer|November 28, 2025
JAK inhibitors for the treatment of life-threatening and refractory immune-related adverse events secondary to immune checkpoint inhibitors: a prospective cohort studyRami Habib, Wilson H Miller, Theodore Papadopoulos, et al.
Blood|August 21, 2004
Expression of SMRTbeta promotes ligand-induced activation of mutated and wild-type retinoid receptorsSylvie Côté, Suzan McNamara, Daria Brambilla, et al.
Cancer|November 11, 2006
Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancerVictor Cohen, Jason S Agulnik, Jonathan Jarry, et al.
Pageof 17